ArticleInternational journal of molecular sciences2024

AAV-NDI1 Therapy Provides Significant Benefit to Murine and Cellular Models of Glaucoma.

Sophia Millington-Ward et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.